Biomea Fusion (NASDAQ:BMEA) reported quarterly losses of $(0.78) per share. This is a 81.4 percent decrease over losses of $(0.43) per share from the same period last year.
Emergent BioSolutions To Sell Travel Health Business to Bavarian Nordic for Up To $380M
Emergent BioSolutions (NYSE:EBS) today announced that it has entered into an agreement to sell its travel health business to Bavarian Nordic (BVNRY) for a total value of up to $380 million, including potential